Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Wash-sale considerations when replacing dividend ETF protect your tax position. This guide outlines rule basics, look-back periods, and compliant practices.
13,645 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
When a prominent executive questions a public pledge with a personal twist, investors and workers feel the reverberat...
Prime Day returns this June with a four-day stretch that doubles the window for spending signals. Here’s how investor...
As Elon Musk crosses a trillion dollars in net worth, the real question for Tesla investors shifts from hype to strat...
A 12-night Wembley residency turns a stadium tour into a financial study for fans and investors alike. This article b...
Tech-focused investors watched TeraWulf surge after a major AI data-center lease deal, signaling potential recurring ...
Ralph Lauren faces a pivotal year in 2026. This article breaks down the brand's strategic moves, potential growth dri...
As May winds down, momentum in U.S. markets has slowed. This guide explains what market losing steam winds mean, how ...
When policy signals delay rate cuts, mining shares can swing on macro tides. This guide explains why these mining sto...
Markets shift from mega-cap tech to overlooked small firms. This story highlights three small-cap ETFs to buy before ...
Two popular short-term bond ETFs—VCSH and ISTB—offer different paths to steady income. This guide breaks down cost, r...
The Janus Henderson AAA CLO ETF draws buyers with a high yield and AAA label, but a hidden tail-risk dynamic could er...